In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 35166-33-7, name is 3-Hydroxymethyl-5-methylisoxazole, introducing its new discovery. SDS of cas: 35166-33-7
Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors
N-Myristoyltransferase (NMT) represents a promising drug target within the parasitic protozoa Trypanosoma brucei (T. brucei), the causative agent for human African trypanosomiasis (HAT) or sleeping sickness. We have previously validated T. brucei NMT as a promising druggable target for the treatment of HAT in both stages 1 and 2 of the disease. We report on the use of the previously reported DDD85646 (1) as a starting point for the design of a class of potent, brain penetrant inhibitors of T. brucei NMT.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 35166-33-7, and how the biochemistry of the body works.SDS of cas: 35166-33-7
Reference£º
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem